- Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia. Leukemia and Lymphoma. 2018 Academic Article GET IT
Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)*.
Leukemia and Lymphoma.
Times cited: 5
Gene-centric meta-analyses of 108 912 individuals confirm known body mass index loci and reveal three novel signals.
Human Molecular Genetics.
Times cited: 56
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
American Journal of Human Genetics.
Times cited: 152